Wikidata

(Q66067207)

English

A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

clinical trial

In more languages

Statements

title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Bosnia and Herzegovina
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Croatia
0 references
Denmark
0 references
Egypt
0 references
Estonia
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Latvia
0 references
Lithuania
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Serbia
0 references
Singapore
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
7 December 2017
0 references
end time
19 December 2019
0 references
number of participants
501
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66067207&oldid=1858742330"